Copyright © 1999 by the European Society of Cardiology.
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study
a Department of Epidemiology & Biostatistics, Erasmus University and University Hospital Rotterdam ‘Dijkzigt’ Rotterdam, The Netherlands
b Department of Cardiology, Thoraxcentre, Erasmus University and University Hospital Rotterdam ‘Dijkzigt’ Rotterdam, The Netherlands
e Department of Medical Informatics, Erasmus University and University Hospital Rotterdam ‘Dijkzigt’ Rotterdam, The Netherlands
f the Division of Cardiology, University of Washington, Seattle, U.S.A.
c the Julius Centre for Patient Oriented Research, Utrecht University, Utrecht, The Netherlands
d Department of General Practice, Utrecht University, Utrecht, The Netherlands
revised July 20, 1998; accepted July 22, 1998
Abstract
Aims
To determine the prevalence of heart failure and symptomatic as well as asymptomatic left ventricular systolic dysfunction in the general population.
Methods and Results
In 5540 participants of the Rotterdam Study (age 68·9±8·7 years, 2251 men) aged 55–95 years, the presence of heart failure was determined by assessment of symptoms and signs (shortness of breath, ankle oedema and pulmonary crepitations) and use of heart failure medication. In 2267 subjects (age 65·7±7·4 years, 1028 men) fractional shortening was measured. The overall prevalence of heart failure was 3·9% (95% CI 3·0±4·7) and did not differ between men and women. The prevalence increased with age, with the exception of the highest age group in men. Fractional shortening was higher in women and did not decrease appreciably with age. The prevalence of left ventricular systolic dysfunction (fractional shortening <=25%) was approximately 2·5 times higher in men (5·5%, 95% CI 4·1–7·0) than in women (2·2%, 95% CI 1·4–3·2). Sixty percent of persons with left ventricular systolic dysfunction had no symptoms or signs of heart failure at all.
Conclusions
The prevalence of heart failure is appreciable and does not differ between men and women. The majority of persons with left ventricular systolic dysfunction can be regarded as having asymptomatic left ventricular systolic dysfunction.
Key Words: Heart failure, epidemiology, prevalence, echocardiography, left ventricular dysfunction, asymptomatic
f1 Correspondence: A. Mosterd, MD PhD, Thoraxcentre, Department of Cardiology BD 402, University Hospital ‘Dijkzigt’, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Julian, DGCamm, AJFox, KFHall, RJCPoole-Wilson, PA
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. van Noord, W. M van der Deure, M. C J M Sturkenboom, S. M J M Straus, A. Hofman, T. J Visser, J. A Kors, J. C M Witteman, and B. H C. Stricker High free thyroxine levels are associated with QTc prolongation in males J. Endocrinol., July 1, 2008; 198(1): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Mahadevan, R C Davis, M P Frenneaux, F D R Hobbs, G Y H Lip, J E Sanderson, and M K Davies Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based? Heart, April 1, 2008; 94(4): 426 - 428. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Swedberg Pure heart rate reduction: further perspectives in heart failure Eur. Heart J. Suppl., September 1, 2007; 9(suppl_F): F20 - F24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-J. L.H.J. Aarnoudse, C. Newton-Cheh, P. I.W. de Bakker, S. M.J.M. Straus, J. A. Kors, A. Hofman, A. G. Uitterlinden, J. C.M. Witteman, and B. H.C. Stricker Common NOS1AP Variants Are Associated With a Prolonged QTc Interval in the Rotterdam Study Circulation, July 3, 2007; 116(1): 10 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pilote, K. Dasgupta, V. Guru, K. H. Humphries, J. McGrath, C. Norris, D. Rabi, J. Tremblay, A. Alamian, T. Barnett, et al. A comprehensive view of sex-specific issues related to cardiovascular disease Can. Med. Assoc. J., March 13, 2007; 176(6): S1 - S44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]
|
|
|
|
|
|
L. C. van Vark, I. Kardys, G. S. Bleumink, A. M. Knetsch, J. W. Deckers, A. Hofman, B. H.Ch. Stricker, and J. C.M. Witteman Lipoprotein-associated phospholipase A2 activity and risk of heart failure: the Rotterdam Study Eur. Heart J., October 1, 2006; 27(19): 2346 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W P Abhayaratna, T H Marwick, W T Smith, and N G Becker Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey Heart, September 1, 2006; 92(9): 1259 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Azevedo, P Bettencourt, P Dias, C Abreu-Lima, H-W Hense, and H Barros Population based study on the prevalence of the stages of heart failure. Heart, August 1, 2006; 92(8): 1161 - 1163. [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Hays, R. L. Sacco, T. Rundek, R. R. Sciacca, Z. Jin, R. Liu, S. Homma, and M. R. Di Tullio Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population Stroke, July 1, 2006; 37(7): 1715 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Qiu, B. Winblad, A. Marengoni, I. Klarin, J. Fastbom, and L. Fratiglioni Heart Failure and Risk of Dementia and Alzheimer Disease: A Population-Based Cohort Study. Arch Intern Med, May 8, 2006; 166(9): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. van der Hooft, J. Heeringa, G. G. Brusselle, A. Hofman, J. C. M. Witteman, J. H. Kingma, M. C. J. M. Sturkenboom, and B. H. Ch. Stricker Corticosteroids and the risk of atrial fibrillation. Arch Intern Med, May 8, 2006; 166(9): 1016 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Heeringa, D. A.M. van der Kuip, A. Hofman, J. A. Kors, G. van Herpen, B. H.Ch. Stricker, T. Stijnen, G. Y.H. Lip, and J. C.M. Witteman Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study Eur. Heart J., April 2, 2006; 27(8): 949 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Chung, S. R. Das, D. Leonard, R. M. Peshock, F. Kazi, S. M. Abdullah, R. M. Canham, B. D. Levine, and M. H. Drazner Women Have Higher Left Ventricular Ejection Fractions Than Men Independent of Differences in Left Ventricular Volume: The Dallas Heart Study Circulation, March 28, 2006; 113(12): 1597 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M.J.M. Straus, J. A. Kors, M. L. De Bruin, C. S. van der Hooft, A. Hofman, J. Heeringa, J. W. Deckers, J. H. Kingma, M. C.J.M. Sturkenboom, B. H. Ch. Stricker, et al. Prolonged QTc Interval and Risk of Sudden Cardiac Death in a Population of Older Adults J. Am. Coll. Cardiol., January 17, 2006; 47(2): 362 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Willems, A Hak, F. Visser, J Cornel, and G van der Wal Patient work in end-stage heart failure: a prospective longitudinal multiple case study Palliative Medicine, January 1, 2006; 20(1): 25 - 33. [Abstract] [PDF]
|
|
|
|
 |
|
 F. H Rutten, K. G M Moons, M.-J. M Cramer, D. E Grobbee, N. P A Zuithoff, J.-W. J Lammers, and A. W Hoes Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study BMJ, December 10, 2005; 331(7529): 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tendera Epidemiology, treatment, and guidelines for the treatment of heart failure in Europe Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J5 - J9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Maggioni Review of the new ESC guidelines for the pharmacological management of chronic heart failure Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J15 - J20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Swedberg and I. Ekman Integrating heart failure guidelines into clinical practice Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J21 - J25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Rutten, M.-J. M. Cramer, D. E. Grobbee, A. P.E. Sachs, J. H. Kirkels, J.-W. J. Lammers, and A. W. Hoes Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease Eur. Heart J., September 2, 2005; 26(18): 1887 - 1894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, K. Swedberg, Writing Committee:, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. A. Smiseth, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur. Heart J., June 1, 2005; 26(11): 1115 - 1140. [Full Text] [PDF]
|
|
|
|
|
|
G I W Galasko, R Senior, and A Lahiri Ethnic differences in the prevalence and aetiology of left ventricular systolic dysfunction in the community: the Harrow heart failure watch Heart, May 1, 2005; 91(5): 595 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Varela-Roman, L Grigorian, E Barge, P Bassante, M G de la Pena, and J R Gonzalez-Juanatey Heart failure in patients with preserved and deteriorated left ventricular ejection fraction Heart, April 1, 2005; 91(4): 489 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S. Thrainsdottir, T. Aspelund, G. Thorgeirsson, V. Gudnason, T. Hardarson, K. Malmberg, G. Sigurdsson, and L. Ryden The Association Between Glucose Abnormalities and Heart Failure in the Population-Based Reykjavik Study Diabetes Care, March 1, 2005; 28(3): 612 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. W. Nielsen, A. Sajedieh, F. Petersen, and J. Fischer Hansen Value of left ventricular filling parameters to predict mortality and functional class in patients with heart disease from the community Eur J Echocardiogr, March 1, 2005; 6(2): 85 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F.C. Schut, G. S. Bleumink, B. H.Ch. Stricker, A. Hofman, J. C.M. Witteman, H. A.P. Pols, J. W. Deckers, J. Deinum, and C. M. van Duijn Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects Eur. Heart J., December 1, 2004; 25(23): 2143 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Di Bari, C. Pozzi, M. C. Cavallini, F. Innocenti, G. Baldereschi, W. De Alfieri, E. Antonini, R. Pini, G. Masotti, and N. Marchionni The diagnosis of heart failure in the community: Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1601 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Doust, P. P. Glasziou, E. Pietrzak, and A. J. Dobson A Systematic Review of the Diagnostic Accuracy of Natriuretic Peptides for Heart Failure Arch Intern Med, October 11, 2004; 164(18): 1978 - 1984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gustafsson, C. Torp-Pedersen, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure Eur. Heart J., October 1, 2004; 25(19): 1711 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Nielsen, T. McDonagh, P. Cowburn, L. Blue, S. D. Robb, and H. Dargie Patient differences related to management in general practice and the hospital: a cross-sectional study of heart failure in the community Eur. Heart J., October 1, 2004; 25(19): 1718 - 1725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N F Murphy, C R Simpson, F A McAlister, S Stewart, K MacIntyre, M Kirkpatrick, J Chalmers, A Redpath, S Capewell, and J J V McMurray National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland Heart, October 1, 2004; 90(10): 1129 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Bleumink, A. M. Knetsch, M. C.J.M. Sturkenboom, S. M.J.M. Straus, A. Hofman, J. W. Deckers, J. C.M. Witteman, and B. H.Ch. Stricker Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: The Rotterdam Study Eur. Heart J., September 2, 2004; 25(18): 1614 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D L Willems, A Hak, F Visser, and G Van der Wal Thoughts of patients with advanced heart failure on dying Palliative Medicine, September 1, 2004; 18(6): 564 - 572. [Abstract] [PDF]
|
|
|
|
|
|
S Shah, M K Davies, D Cartwright, and P Nightingale Management of chronic heart failure in the community: role of a hospital based open access heart failure service Heart, July 1, 2004; 90(7): 755 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hammerer-Lercher, W. Ludwig, G. Falkensammer, S. Muller, E. Neubauer, B. Puschendorf, O. Pachinger, and J. Mair Natriuretic Peptides as Markers of Mild Forms of Left Ventricular Dysfunction: Effects of Assays on Diagnostic Performance of Markers Clin. Chem., July 1, 2004; 50(7): 1174 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Hequet, Q.H. Le, I. Moullet, E. Pauli, G. Salles, D. Espinouse, C. Dumontet, C. Thieblemont, P. Arnaud, D. Antal, et al. Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults J. Clin. Oncol., May 15, 2004; 22(10): 1864 - 1871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B A Groenning, I Raymond, P R Hildebrandt, J C Nilsson, M Baumann, and F Pedersen Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population Heart, March 1, 2004; 90(3): 297 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tendera The epidemiology of heart failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1_suppl): S2 - S6. [Abstract] [PDF]
|
|
|
|
|
|
K. Hogg, K. Swedberg, and J. McMurray Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis J. Am. Coll. Cardiol., February 4, 2004; 43(3): 317 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamaguchi, J. Yoshida, K. Yamamoto, Y. Sakata, T. Mano, N. Akehi, M. Hori, Y.-J. Lim, M. Mishima, and T. Masuyama Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy J. Am. Coll. Cardiol., January 7, 2004; 43(1): 55 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I Raymond, F Pedersen, F Steensgaard-Hansen, A Green, M Busch-Sorensen, C Tuxen, J Appel, J Jacobsen, D Atar, and P Hildebrandt Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen Heart, December 1, 2003; 89(12): 1422 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Wang, D. Levy, E. J. Benjamin, and R. S. Vasan The Epidemiology of "Asymptomatic" Left Ventricular Systolic Dysfunction: Implications for Screening Ann Intern Med, June 3, 2003; 138(11): 907 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Lips, L. J. deWindt, D. J.W. van Kraaij, and P. A. Doevendans Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy Eur. Heart J., May 2, 2003; 24(10): 883 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Pina, C. S. Apstein, G. J. Balady, R. Belardinelli, B. R. Chaitman, B. D. Duscha, B. J. Fletcher, J. L. Fleg, J. N. Myers, and M. J. Sullivan Exercise and Heart Failure: A Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention Circulation, March 4, 2003; 107(8): 1210 - 1225. [Full Text] [PDF]
|
|
|
|
|
|
J.G.F Cleland, K Swedberg, F Follath, M Komajda, A Cohen-Solal, J.C Aguilar, R Dietz, A Gavazzi, R Hobbs, J Korewicki, et al. The EuroHeart Failure survey programme--a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis Eur. Heart J., March 1, 2003; 24(5): 442 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Lakatta and D. Levy Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part II: The Aging Heart in Health: Links to Heart Disease Circulation, January 21, 2003; 107(2): 346 - 354. [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Redfield, S. J. Jacobsen, J. C. Burnett Jr, D. W. Mahoney, K. R. Bailey, and R. J. Rodeheffer Burden of Systolic and Diastolic Ventricular Dysfunction in the Community: Appreciating the Scope of the Heart Failure Epidemic JAMA, January 8, 2003; 289(2): 194 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Nielsen, T. A. McDonagh, S. D. Robb, and H. J. Dargie Retrospective analysis of thecost-effectiveness of using plasmabrain natriuretic peptide inscreening for left ventricularsystolic dysfunction in the general population J. Am. Coll. Cardiol., January 1, 2003; 41(1): 113 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Gottdiener, R. L. McClelland, R. Marshall, L. Shemanski, C. D. Furberg, D. W. Kitzman, M. Cushman, J. Polak, J. M. Gardin, B. J. Gersh, et al. Outcome of Congestive Heart Failure in Elderly Persons: Influence of Left Ventricular Systolic Function: The Cardiovascular Health Study Ann Intern Med, October 15, 2002; 137(8): 631 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J G F Cleland Contemporary management of heart failure in clinical practice Heart, October 1, 2002; 88(90002): ii5 - 8. [Full Text] [PDF]
|
|
|
|
|
|
A Varela-Roman, J R Gonzalez-Juanatey, P Basante, R Trillo, J Garcia-Seara, J L Martinez-Sande, and F Gude Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction Heart, September 1, 2002; 88(3): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Heiat, C. P. Gross, and H. M. Krumholz Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials Arch Intern Med, August 12, 2002; 162(15): 1682 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yamamoto, T. Masuyama, Y. Sakata, N. Nishikawa, T. Mano, J. Yoshida, T. Miwa, M. Sugawara, Y. Yamaguchi, T. Ookawara, et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart Cardiovasc Res, July 1, 2002; 55(1): 76 - 82. [Abstract] [Full Text] [PDF] |